2008
DOI: 10.1016/j.cca.2007.12.006
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a new point of care automated complete blood count (CBC) analyzer in various clinical settings

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
25
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(27 citation statements)
references
References 5 publications
1
25
0
Order By: Relevance
“…The HemoScreen imprecision values were found to be within the allowable total errors as defined by CLIA guidelines14 and are acceptable in accordance with desirable specifications for imprecision as determined by different models 15 16. The observed CV percentages are also equivalent to those previously reported for several FDA-cleared haematology POC analysers 17 18. The HemoScreen provides CBC results, which are comparable with the reference method with r values of 0.92 or greater.…”
Section: Discussionsupporting
confidence: 77%
“…The HemoScreen imprecision values were found to be within the allowable total errors as defined by CLIA guidelines14 and are acceptable in accordance with desirable specifications for imprecision as determined by different models 15 16. The observed CV percentages are also equivalent to those previously reported for several FDA-cleared haematology POC analysers 17 18. The HemoScreen provides CBC results, which are comparable with the reference method with r values of 0.92 or greater.…”
Section: Discussionsupporting
confidence: 77%
“…It measures a 3 part differential WBC, RBC and platelet counts with a single disposable cartridge. [7][8][9] All these devices have been CE marked (Europe) and 510k approved (US), which allows their use in the clinical environment by trained professionals. They are not, however, approved for 'self-testing' use by the patient.…”
mentioning
confidence: 99%
“…Optical detection was chosen for particle detection and characterization because of the range of inexpensive optical sources and detectors 22-24 and the ability to carry out a wide range of assays including fluorescence. While electrical impedance methods are attractive due to their small size and reduced system complexity 25-28 , impedance based methods are limited in assay menus for a generalized clinical measurement platform. To extend the simplicity of the inertial focusing chip, we sought to decrease the complexity and the size of the optical system by incorporating optical elements within the microfluidic chip that contains the flow cell.…”
Section: Discussionmentioning
confidence: 99%